Enfortumab Vedotin and Pembrolizumab doubled survival rates, with fewer serious side effects in advanced bladder cancer.
pull down to refresh
5 sats \ 1 reply \ @SimpleStacker 31 May
Cool, but what is it?
reply
0 sats \ 0 replies \ @zuspotirko OP 1 Jun
a drug consisting of 2 parts
reply
0 sats \ 0 replies \ @aljaz 1 Jun
Imagine if we actually eliminated the reasons people get it at all
reply